Celadon Pharmaceuticals PLC Capital Reinvestment Ratio

Latest as of June 2020: 1.27x

Celadon Pharmaceuticals PLC capital reinvestment ratio. Celadon Pharmaceuticals PLC (CEL) has a Capital Reinvestment Ratio of 1.27x as of June 2020, meaning it reinvests 1% of its operating cash flow (GBX109.70K) in capital expenditures (GBX139.75K). Check Celadon Pharmaceuticals PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.27x

Capex / Operating Cash Flow

Operating Cash Flow

GBX109.70K

GBX

Capital Expenditures

GBX139.75K

GBX

Data as of

Jun 2020

Most recent filing

Celadon Pharmaceuticals PLC Capital Reinvestment Ratio by Year (None–None)

Celadon Pharmaceuticals PLC capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Celadon Pharmaceuticals PLC cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow